Literature DB >> 25940966

Contemporary cardiac issues in Duchenne muscular dystrophy. Working Group of the National Heart, Lung, and Blood Institute in collaboration with Parent Project Muscular Dystrophy.

Elizabeth M McNally1, Jonathan R Kaltman1, D Woodrow Benson2, Charles E Canter2, Linda H Cripe2, Dongsheng Duan2, Jonathan D Finder2, William J Groh, Eric P Hoffman2, Daniel P Judge2, Naomi Kertesz2, Kathi Kinnett2, Roxanne Kirsch2, Joseph M Metzger2, Gail D Pearson2, Jill A Rafael-Fortney2, Subha V Raman2, Christopher F Spurney2, Shari L Targum2, Kathryn R Wagner2, Larry W Markham1.   

Abstract

Entities:  

Keywords:  cardiomyopathy; dystrophin; heart failure; magnetic resonance imaging; muscular dystrophy

Mesh：

Substances：

Year:  2015        PMID： 25940966      PMCID： PMC4573596          DOI： 10.1161/CIRCULATIONAHA.114.015151

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  77 in total

1.  Eplerenone in patients with systolic heart failure and mild symptoms.

Authors:  Faiez Zannad; John J V McMurray; Henry Krum; Dirk J van Veldhuisen; Karl Swedberg; Harry Shi; John Vincent; Stuart J Pocock; Bertram Pitt
Journal:  N Engl J Med       Date:  2010-11-14       Impact factor: 91.245

2.  Sildenafil does not improve cardiomyopathy in Duchenne/Becker muscular dystrophy.

Authors:  Doris G Leung; Daniel A Herzka; W Reid Thompson; Bing He; Genila Bibat; Gihan Tennekoon; Stuart D Russell; Karl H Schuleri; Albert C Lardo; David A Kass; Richard E Thompson; Daniel P Judge; Kathryn R Wagner
Journal:  Ann Neurol       Date:  2014-07-10       Impact factor: 10.422

3.  Age-matched comparison reveals early electrocardiography and echocardiography changes in dystrophin-deficient dogs.

Authors:  Deborah M Fine; Jin-Hong Shin; Yongping Yue; Dietrich Volkmann; Stacey B Leach; Bruce F Smith; Mark McIntosh; Dongsheng Duan
Journal:  Neuromuscul Disord       Date:  2011-05-13       Impact factor: 4.296

Review 4.  New approaches in the therapy of cardiomyopathy in muscular dystrophy.

Authors:  Elizabeth M McNally
Journal:  Annu Rev Med       Date:  2007       Impact factor: 13.739

Review 5.  Consequences of disrupting the dystrophin-sarcoglycan complex in cardiac and skeletal myopathy.

Authors:  Ahlke Heydemann; Elizabeth M McNally
Journal:  Trends Cardiovasc Med       Date:  2007-02       Impact factor: 6.677

6.  Beta-blocker therapy for cardiac dysfunction in patients with muscular dystrophy.

Authors:  Hidemi Kajimoto; Keiko Ishigaki; Kenichi Okumura; Hirofumi Tomimatsu; Makoto Nakazawa; Kayoko Saito; Makiko Osawa; Toshio Nakanishi
Journal:  Circ J       Date:  2006-08       Impact factor: 2.993

7.  Prevention of dystrophin-deficient cardiomyopathy in twenty-one-month-old carrier mice by mosaic dystrophin expression or complementary dystrophin/utrophin expression.

Authors:  Brian Bostick; Yongping Yue; Chun Long; Dongsheng Duan
Journal:  Circ Res       Date:  2007-10-25       Impact factor: 17.367

8.  Sub-physiological sarcoglycan expression contributes to compensatory muscle protection in mdx mice.

Authors:  Dejia Li; Chun Long; Yongping Yue; Dongsheng Duan
Journal:  Hum Mol Genet       Date:  2009-01-08       Impact factor: 6.150

9.  Carvedilol for children and adolescents with heart failure: a randomized controlled trial.

Authors:  Robert E Shaddy; Mark M Boucek; Daphne T Hsu; Robert J Boucek; Charles E Canter; Lynn Mahony; Robert D Ross; Elfriede Pahl; Elizabeth D Blume; Debra A Dodd; David N Rosenthal; Jeri Burr; Bernie LaSalle; Richard Holubkov; Mary Ann Lukas; Lloyd Y Tani
Journal:  JAMA       Date:  2007-09-12       Impact factor: 56.272

10.  Prevalence and distribution of late gadolinium enhancement in a large population of patients with Duchenne muscular dystrophy: effect of age and left ventricular systolic function.

Authors:  Kan N Hor; Michael D Taylor; Hussein R Al-Khalidi; Linda H Cripe; Subha V Raman; John L Jefferies; Robert O'Donnell; D Woodrow Benson; Wojciech Mazur
Journal:  J Cardiovasc Magn Reson       Date:  2013-12-21       Impact factor: 5.364
View more
  110 in total

1.  Central Arterial Function Measured by Non-invasive Pulse Wave Analysis is Abnormal in Patients with Duchenne Muscular Dystrophy.

Authors:  Thomas D Ryan; John J Parent; Zhiqian Gao; Philip R Khoury; Elizabeth Dupont; Jennifer N Smith; Brenda Wong; Elaine M Urbina; John L Jefferies
Journal:  Pediatr Cardiol       Date:  2017-06-21       Impact factor: 1.655

2.  Single SERCA2a Therapy Ameliorated Dilated Cardiomyopathy for 18 Months in a Mouse Model of Duchenne Muscular Dystrophy.

Authors:  Nalinda B Wasala; Yongping Yue; William Lostal; Lakmini P Wasala; Nandita Niranjan; Roger J Hajjar; Gopal J Babu; Dongsheng Duan
Journal:  Mol Ther       Date:  2020-01-10       Impact factor: 11.454

3.  Generation of Duchenne muscular dystrophy patient-specific induced pluripotent stem cell line lacking exons 45-50 of the dystrophin gene (IITi001-A).

Authors:  Binyamin Eisen; Ronen Ben Jehuda; Ashley J Cuttitta; Lucy N Mekies; Irina Reiter; Sindhu Ramchandren; Michael Arad; Daniel E Michele; Ofer Binah
Journal:  Stem Cell Res       Date:  2018-04-03       Impact factor: 2.020

4.  Myocardial Strain Using Cardiac MR Feature Tracking and Speckle Tracking Echocardiography in Duchenne Muscular Dystrophy Patients.

Authors:  Bryan Siegel; Laura Olivieri; Heather Gordish-Dressman; Christopher F Spurney
Journal:  Pediatr Cardiol       Date:  2017-11-29       Impact factor: 1.655

5.  Letter Regarding: "Evaluation of Early Left Ventricular Dysfunction in Patients with Duchenne Muscular Dystrophy Using Two-Dimensional Speckle Tracking Echocardiography and Tissue Doppler Imaging," Cho et al., Pediatric Cardiology ePub July 2018.

Authors:  Thomas D Ryan
Journal:  Pediatr Cardiol       Date:  2018-09-20       Impact factor: 1.655

6.  Cardiomyopathy in Muscular Dystrophy: When to Treat?

Authors:  Elizabeth M McNally
Journal:  JAMA Cardiol       Date:  2017-02-01       Impact factor: 14.676

7.  Duchenne muscular dystrophy: CRISPR/Cas9 treatment.

Authors:  Jerry R Mendell; Louise R Rodino-Klapac
Journal:  Cell Res       Date:  2016-03-01       Impact factor: 25.617

8.  Acute Myocardial Injury in a Child with Duchenne Muscular Dystrophy: Pulse Steroid Therapy?

Authors:  Eliza Cinteza; Claudiu Stoicescu; Niculina Butoianu; Mihaela Balgradean; Alin Nicolescu; Matthias Angrés
Journal:  Maedica (Bucur)       Date:  2017-09

Review 9.  Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management.

Authors:  David J Birnkrant; Katharine Bushby; Carla M Bann; Benjamin A Alman; Susan D Apkon; Angela Blackwell; Laura E Case; Linda Cripe; Stasia Hadjiyannakis; Aaron K Olson; Daniel W Sheehan; Julie Bolen; David R Weber; Leanne M Ward
Journal:  Lancet Neurol       Date:  2018-02-03       Impact factor: 44.182

10.  Mesodermal iPSC-derived progenitor cells functionally regenerate cardiac and skeletal muscle.

Authors:  Mattia Quattrocelli; Melissa Swinnen; Giorgia Giacomazzi; Jordi Camps; Ines Barthélemy; Gabriele Ceccarelli; Ellen Caluwé; Hanne Grosemans; Lieven Thorrez; Gloria Pelizzo; Manja Muijtjens; Catherine M Verfaillie; Stephane Blot; Stefan Janssens; Maurilio Sampaolesi
Journal:  J Clin Invest       Date:  2015-11-16       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.